SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 1, doi. 10.61186/vacres.10.1.1
- By:
- Publication type:
- Article
Works matching IS 23832819 AND DT 2023 AND VI 10 AND IP 1
Results: 6
1
2
Expression of a Novel Fusion Recombinant Protein VP8-VP1 in Escherichia coli as a Rota-HAV Vaccine Candidate.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 34, doi. 10.61186/vacres.10.1.34
- By:
- Publication type:
- Article
3
In silico Evaluation, Cloning, and Expression of Omp22 as a Promising Vaccine Candidate against Acinetobacter baumannii.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 11, doi. 10.61186/vacres.10.1.11
- By:
- Publication type:
- Article
4
Novel Protein Expression and Purification of SARS CoV-2 from Recombinant Escherichia coli System.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 6, doi. 10.61186/vacres.10.1.6
- By:
- Publication type:
- Article
5
In-Silico Design of a Novel Multi-Epitope Fimbriae Vaccine against Non-typhoidal Salmonella.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 23, doi. 10.61186/vacres.10.1.23
- By:
- Publication type:
- Article
6
Evaluation of the Effectiveness of Polyclonal Antibody Developed against a Recombinant Multi-Epitope Protein Composed of Uropathogenic Escherichia coli Antigens.
- Published in:
- Vaccine Research, 2023, v. 10, n. 1, p. 18, doi. 10.61186/vacres.10.1.18
- By:
- Publication type:
- Article